Joint Approach cover art

All Episodes

Joint Approach — 67 episodes

#
Title
1

ICM Guidelines Discussion: "Is there a role for suppressive antibiotic treatment (SAT) only in patients with PJI?” Part 2

2

ICM Guidelines Discussion: "Is there a role for Suppressive Antibiotic Treatment only in patients with PJI?” Part 1

3

ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 2

4

ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 1

5

Shouldering the Burden: A New Era for Diagnosing Shoulder Prosthetic Joint Infections Part 2

6

Shouldering the Burden: A New Era for Diagnosing Shoulder Prosthetic Joint Infections Part 1

7

Bugged and Baffled: A Case with Meredith Schade and Stephanie Hawkins

8

Dalbavancin/Oritavancin for treatment of PJI Part 3

9

Dalbavancin/Oritavancin for treatment of PJI Part 2

10

Dalbavancin/Oritavancin for Treatment of PJI Part 1

11

The Psychosocial Impact of Orthopedic Joint Infections

12

Spinal Implant Infections Part 2

13

Spinal Implant Infections Part 1

14

Bugged and Baffled: A Case with Angela Hewlett and Curtis Hartman

15

Innovative Approaches to Bone and Joint Infections Part 3

16

Innovative Approaches to Bone and Joint Infections Part 2

17

Innovative Approaches to Bone and Joint Infections Part 1

18

Bugged and Baffled: Case 2 with Jenny Aronson

19

Bugged and Baffled: Case 1 with Jenny Aronson

20

Megaprostheses Part 2

21

Megaprostheses Part 1

22

Bugged and Baffled: A Case with Alaina Ritter and Minu Abraham

23

Bugged and Baffled: A Case with Jakrapun Pupaibool

24

PJI- Patient Perspective Part 2

25

PJI - Patient Perspective Part 1

26

Bugged and Baffled: A Case with Andy Miller

27

Persistent and Challenging Orthopedic Infections: Biofilm Part 2

28

Persistent and Challenging Orthopedic Infections: Biofilm Part 1

29

Shoulder PJI Part 2

30

Shoulder PJI Part 1

31

Diabetic Foot Infections Part 2

32

Diabetic Foot Infections Part 1

33

Dental Prophylaxis for Patients Who Have Undergone Total Joint Arthroplasty

34

Fracture Related Infections Part 2

35

Fracture Related Infections Part 1

36

One and Done or Two to Tango? 1 vs. 2-Stage Procedures for the Treatment of PJI Part 2

37

One and Done or Two to Tango? 1- vs. 2-Stage Procedures for the Treatment of PJI Part 1

38

Plasma Microbial Cell-free DNA Next-generation Sequencing can be a Useful Diagnostic Tool in Patients with Osteoarticular Infections

39

Evaluating the Safety and Efficacy of Low-dose Chlorhexidine Gluconate Irrigation for Open Fracture Management

40

Complete Eradication of Biofilm Using Low Frequency Electromagnetic Force (EMF) and Antibiotics at MIC

41

Suppressive Antibiotic Therapy in Patients With Prosthetic Joint Infection and Retained Hardware: How Much is Enough?

42

A Novel Isotropic Optical Fiber: Antimicrobial Effect of Blue Light on Drug Resistant Organisms

43

Unsupervised Machine Learning Can Group Synovial Fluid Samples into Disease-Relevant Clusters: AI Diagnosis is Near!

44

The Comparative Analysis of 1.5-Stage and 2-Stage Revision for Periprosthetic Infection after Total Hip Arthroplasty. Is 1.5-Stage Really Equivalent?

45

The Timing of Acute Periprosthetic Joint Infection of Total Knee Arthroplasty does not affect failure rates for DAIR

46

Oral Antibiotics Part 2

47

Oral Antibiotics Part 1

48

Bacteria Phages and How They Can Be Used to Treat Bone and Joint Infections Part 2

49

Bacteria Phages and How They Can Be Used to Treat Bone and Joint Infections Part 1

50

Surgical Site Infection Prevention Part 3

51

Surgical Site Infection Prevention Part 2

52

Surgical Site Infection Prevention Part 1

53

Conversations from the 33rd Annual Open Scientific Meeting: Ryan Khodadadi

54

Conversations from the 33rd Annual Open Scientific Meeting: Gabriel Linden

55

Conversations from the 33rd Annual Open Scientific Meeting: Marjorie Golden

56

Conversations from the 33rd Annual Open Scientific Meeting: Geno Tai

57

Conversations from the 33rd Annual Open Scientific Meeting: Emily Treu

58

Conversations from the 33rd Annual Open Scientific Meeting: Irene Sigmund

59

Conversations from the 33rd Annual Open Scientific Meeting: Douglas Chonko

60

Conversations from the 33rd Annual Open Scientific Meeting: Benjamin Levy

61

Conversations from the 33rd Annual Open Scientific Meeting: Hussam Tabaja

62

Conversations from the 33rd Annual Open Scientific Meeting: Allison Lastinger and Matthew Dietz

63

Conversations from the 33rd Annual Open Scientific Meeting: Brian Klatt

64

Treatment of Infection with Systemic Antibiotics

65

How To Take and Interpret Cultures: Part 2: Intraoperative Diagnostics

66

How To Take and Interpret Cultures: Part 1: Pre-operative Diagnostics

67

Working Together as a Team